» Articles » PMID: 32553485

Corneal Wound Healing

Overview
Journal Exp Eye Res
Specialty Ophthalmology
Date 2020 Jun 20
PMID 32553485
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

The corneal wound healing response is typically initiated by injuries to the epithelium and/or endothelium that may also involve the stroma. However, it can also be triggered by immune or infectious processes that enter the stroma via the limbal blood vessels. For mild injuries or infections, such as epithelial abrasions or mild controlled microbial infections, limited keratocyte apoptosis occurs and the epithelium or endothelium regenerates, the epithelial basement membrane (EBM) and/or Descemet's basement membrane (DBM) is repaired, and keratocyte- or fibrocyte-derived myofibroblast precursors either undergo apoptosis or revert to the parent cell types. For more severe injuries with extensive damage to EBM and/or DBM, delayed regeneration of the basement membranes leads to ongoing penetration of the pro-fibrotic cytokines transforming growth factor (TGF) β1, TGFβ2 and platelet-derived growth factor (PDGF) that drive the development of mature alpha-smooth muscle actin (SMA)+ myofibroblasts that secrete large amounts of disordered extracellular matrix (ECM) components to produce scarring stromal fibrosis. Fibrosis is dynamic with ongoing mitosis and development of SMA + myofibroblasts and continued autocrine-or paracrine interleukin (IL)-1-mediated apoptosis of myofibroblasts and their precursors. Eventual repair of the EBM and/or DBM can lead to at least partial resolution of scarring fibrosis.

Citing Articles

Therapeutic Assessment of Diverse Doxycycline-Based Formulations in Promoting Deep Corneal Wound Healing: Evidence from a Rat Model.

Chan S, Tseng C, Huang W, Lin C Vet Sci. 2025; 12(2).

PMID: 40005905 PMC: 11860526. DOI: 10.3390/vetsci12020143.


Ultrastructural Aspects of Corneal Functional Recovery in Rats Following Intrastromal Keratocyte Injection.

Ma Q, Riau A, Young R, Bell J, Shebanova O, Terrill N Invest Ophthalmol Vis Sci. 2025; 66(2):45.

PMID: 39964324 PMC: 11838119. DOI: 10.1167/iovs.66.2.45.


Navigating the path to corneal healing success and challenges: a comprehensive overview.

Shadmani A, Wu A Eye (Lond). 2025; .

PMID: 39939391 DOI: 10.1038/s41433-025-03619-2.


RHO-Associated Coiled-Coil-Containing Protein Kinase Inhibitors Significantly Modulate the Epithelial-Mesenchymal Transition Induced by TGF-β2 in the 2-D and 3-D Cultures of Human Corneal Stroma Fibroblasts.

Umetsu A, Ida Y, Sato T, Higashide M, Nishikiori N, Furuhashi M Biomedicines. 2025; 12(12.

PMID: 39767691 PMC: 11673340. DOI: 10.3390/biomedicines12122784.


Biologically inspired bioactive hydrogels for scarless corneal repair.

Huang J, Jiang T, Qie J, Cheng X, Wang Y, Ye Y Sci Adv. 2024; 10(51):eadt1643.

PMID: 39693435 PMC: 11654680. DOI: 10.1126/sciadv.adt1643.


References
1.
Ko J, Yanai R, Chikama T, Nishida T . Downregulation of matrix metalloproteinase-2 in corneal fibroblasts by interleukin-1 receptor antagonist released from corneal epithelial cells. Invest Ophthalmol Vis Sci. 2010; 51(12):6286-93. DOI: 10.1167/iovs.09-4753. View

2.
Wilson S, Walker J, Chwang E, He Y . Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993; 34(8):2544-61. View

3.
Wilson S, Lloyd S, He Y . EGF, basic FGF, and TGF beta-1 messenger RNA production in rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci. 1992; 33(6):1987-95. View

4.
Li Q, Weng J, Mohan R, Bennett G, Schwall R, Wang Z . Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci. 1996; 37(5):727-39. View

5.
Jester J, Cavanagh H, Petroll W . Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996; 15(5):505-16. View